CHICAGO, June 9 (UPI) -- The American Medical Association may publicly take a stand against adding warnings to antidepressants used for teens and children, a published report said.
The AMA is considering the move, which is at odds with Food and Drug Administration policy, at its conference later this month in Chicago, the Chicago Tribune said.
The report said those behind the anti-warning proposal say it is designed to combat a recent, rapid decline in prescriptions and ensure children and adolescents are getting proper treatment for depression.
The FDA has ordered "black-box" warnings be put on anti-depressants, noting the risk of suicidal tendencies among young users.
But the report said critics predict confusion will reign if the nation's largest doctors' group opposes the FDA labeling and declares the agency has been too stern on antidepressants -- especially during a time the agency is under criticism for lax oversight of drug safety.
